Both the leads are compatible with the Attain family of exclusive delivery tools including the Attain Select II, the Attain Hybrid Guide Wires and Attain Command.
As part of Medtronic’s fully integrated CRT systems, the entire Attain portfolio can be used with both the Protecta and Vision 3D portfolios of CRT-Ds and CRT-Ps.
Medtronic said Attain Ability Plus enables physicians to reach and maintain the target vein, providing stability in medium-to-large venous anatomies, while Attain Ability Straight allows physicians to maneuver through small cardiac veins.
The design of the leads, combined with their capacity to be delivered via the Attain Select II, a sub-selection catheter (in leads = 88 cm in length), assists physicians in placing the lead directly in difficult to reach locations in the heart.
According to clinical studies conducted on these leads, approximately 94% of physicians positively rated the ability to position the Attain Ability Plus lead to the desired cardiac veins, with a one-month complication-free rate of 98.5%.
Additionally, 96.8% of physicians positively rated the handling of the Attain Ability Straight and the ability to maneuver it to the appropriate veins, with a low lead-dislodgement rate of 3.2%.
In addition to the US, the Attain Ability family of left-heart leads is available in Australia, Canada, Europe, Greece, Israel, Japan, Malaysia, New Zealand and the Middle East.
